Partner Saar Pauker’s article “Admissibility of claims in investment treaty arbitration” was recenetly published at the Arbitration International Journal. The article argues

Admissibility of claims in investment treaty arbitration

Herzog Fox & Neeman represented Foamix Pharmaceuticals Ltd., an Israeli bio-tech company, as they successfully filed their first prospectus as

Herzog Fox & Neeman Represented Foamix Pharmaceuticals Ltd. in Its First Prospectus as a Domestic U.S. Filer

On March 18, 2018, the Law for Reducing the Use of Cash, 2018 (the “Law”) was published in the Official

Adler Real Estate AG, a publicly-traded German real-estate company, completed an acquisition of a controlling stake in Brack Capital Properties

Herzog Fox & Neeman Advised Adler Real Estate AG in Completing Its Acquisition of a Controlling Stake in Brack Capital Properties N.V.

We are delighted to have been crowned the Largest Israeli Law Firm by Dun’s 100, for the fourth consecutive year.

Herzog Fox & Neeman Recognised as Israel’s Largest Law Firm by Dun’s 100

We would like to draw your attention to the fact that a new procedure has recently been published, which establishes

On March 19, 2018, the updated draft of the Agreement on the Withdrawal of the United Kingdom from the European

Client Update | Brexit’s Effects on Intellectual Property Rights Protection

We are pleased to introduce you to our March edition of the Technology & Regulation Client Update, which includes several

Herzog Fox & Neeman welcomes you to the 2018 Annual Antitrust and Competition Conference, presenting the latest updates and expected

360 Degrees of Competition Law | Annual Antitrust Conference | 20.3.18

Dear Clients and Colleagues, On March 5, 2018 the Israeli parliament passed the Insolvency and Rehabilitation Law, 2018 (the “Law”).

Client Update | The Insolvency and Rehabilitation Law, 2018

Further to our previous updates on the matter, we wish to advise you regarding three significant developments that have taken